Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06900712 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Positive Processes and Transition to Health - Single-Session (PATH-SS)

Study acronym: PATH-SS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 22, 2026 (before its estimated August 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 31, 2026 to Aug 31, 2026
    • Study completion date: May 31, 2026 to May 31, 2027
    • Eligibility criteria shortened, about 19 words
    • Study description expanded, about 1 word
    v3
  2. Start date changed from estimate of Mar 2025 to Jul 17, 2025
    • Primary completion date: Feb 28, 2026 to Mar 31, 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to test a brief, new psychotherapy (called Positive Processes and Transition to Health - Single Session, or PATH-SS) that aims to provide relief for people who are suffering after experiencing a sexual assault. This research will explore whether this new psychotherapy reduces sexual assault related distress, including posttraumatic stress and depression symptoms. The main questions it aims to answer are: Does PATH-SS leads to improvements in PTSD and depression symptoms (pre- to post- and 1-month follow-up)? Do participants perceive PATH-SS to be acceptable, helpful, and do they complete/adhere to treatment? Participants will complete a pre-treatment/baseline assessment to confirm eligibility, and those who are eligible will receive the single-session intervention and will complete a post-treatment and a 1-month follow-up assessment of stressor-related symptoms.
Trial Details
NCT Number NCT06900712
Lead Sponsor Case Western Reserve University
Conditions
(from sponsor)		 PTSD, Depression
Related terms Depression, Stress Disorders, Post-Traumatic, Wounds and Injuries
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov